Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus Infection  by Kapadia, Sharookh B. et al.
Immunity, Vol. 17, 143–155, August, 2002, Copyright 2002 by Cell Press
Critical Role of Complement and Viral
Evasion of Complement in Acute, Persistent,
and Latent -Herpesvirus Infection
cell surface expressed RCA protein homologs, or ex-
pression of structurally unrelated complement regula-
tory proteins (Saifuddin et al., 1995; Spear et al., 1995;
Takefman et al., 1998; Rother et al., 1995; Hirsch et al.,
1980b).
Sharookh B. Kapadia,1 Beth Levine,2
Samuel H. Speck,3,4 and Herbert W. Virgin, IV1,4
1Department of Immunology and Pathology
Department of Molecular Microbiology
Washington University School of Medicine
-herpesviruses establish life-long infection in the ma-Box 8118
jority of humans, with diseases including cancer oc-660 South Euclid Avenue
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eral oncogenic -herpesviruses, including the human2 Department of Medicine
Kaposi’s sarcoma-associated herpesvirus (KSHV), theColombia University College of Physicians
primate herpesvirus saimiri (HVS), and the murineand Surgeons
HV68, encode RCA protein homologs (Russo et al.,New York, New York 10032
1996; Virgin et al., 1997; Rother et al., 1994; Fodor et3 Department of Microbiology and Immunology
al., 1995; Albrecht and Fleckenstein, 1992; Kapadia etYerkes Regional Primate Center
al., 1999), but their role in infection is unknown. TheEmory University
HV68 and HVS RCA proteins inhibit complement acti-954 Gatewood Road NE
vation in vitro at the level of C3 and/or C4 depositionAtlanta, Georgia 30329
(Virgin et al., 1997; Kapadia et al., 1999; Rother et al.,
1994; Fodor et al., 1995; Albrecht and Fleckenstein,
1992). The HV68 RCA protein has both a soluble iso-Summary
form, which inhibits C3 activation via both the classical
and alternative pathways, as well as an isoform ex-Several -herpesviruses encode homologs of host
pressed on infected cell surfaces and virions (Kapadiaregulators of complement activation (RCA) proteins,
et al., 1999; Gangappa et al., submitted).suggesting that they have evolved immune evasion
The HV68 RCA protein is not essential for HV68strategies targeting complement. We evaluated the
replication in cultured cells (Adler et al., 2000), sug-role of complement factor C3 (C3) and the murine
gesting that the virus encodes this protein to evade the-herpesvirus 68 (HV68) RCA protein in viral patho-
host response to infection rather than to assist in viralgenesis. Deletion of the HV68 RCA protein decreased
replication per se. The conservation of RCA proteins invirulence during acute CNS infection, and this attenua-
several -herpesviruses also suggests the hypothesistion was specifically reversed by deletion of host C3.
that complement plays a protective role in host defenseThe HV68 RCA protein was also important for persis-
against these viruses. However, since proteins withtent viral replication and virulence in IFNR/ mice.
SCRs can have functions other than complement regula-In addition, C3 played a role in regulating latency, but
tion (del Mar et al., 1998; Isaacs et al., 1992b; Martinez-this was not counteracted by the HV68 RCA protein.
Pomares et al., 1993; Engelstad and Smith, 1993; WolffeWe conclude that complement is a key host defense
et al., 1993; Takahashi-Nishimaki et al., 1991; Herreraagainst -herpesvirus infection and that -herpesvi-
et al., 1998; Mathew et al., 1998; Laquerre et al., 1998;ruses have evolved an immune evasion strategy that
Sears et al., 1991; Lubinski et al., 1998), it is possibleis effective against complement-mediated antiviral re-
that the function of the -herpesvirus SCR-containingsponses during acute but not latent infection.
RCA proteins is not related to complement.
To address the hypothesis that complement is an im-
Introduction
portant host defense against -herpesvirus infection,
we assessed the role of C3 and the HV68 RCA protein
Complement plays a protective role in the acute host in three components of HV68 infection in vivo: (1) viral
response against several viruses (Lewis et al., 1986; replication and virulence during acute infection, (2) viral
Rundell and Betts, 1982; Davis-Poynter and Farrell, replication and virulence during persistent infection of
1996; Hicks et al., 1978; Hirsch et al., 1980a, 1980b; immunocompromised mice, and (3) establishment of
Leddy et al., 1977), and therefore it is not surprising that and reactivation from viral latency. HV68 provides a
viruses have developed strategies to block the effects of useful model for these studies since it is closely related
complement. The host uses a family of proteins termed to Epstein Barr virus (EBV), HVS, and KSHV (Efstathiou
regulators of complement activation (RCA proteins) con- et al., 1990a, 1990b; Virgin et al., 1997) but infects labora-
taining multiple copies of an approximately 60 amino tory mice (Mistrikova and Blaskovic, 1985; Rajcani et
acid domain called the short consensus repeat (SCR) to al., 1985; Blaskovic et al., 1980; Terry et al., 2000; Sunil-
prevent damage to host cells by activated complement Chandra et al., 1992).
(Liszewski et al., 1996; Reid and Day, 1989). Viral strate- During acute infection, HV68 causes pneumonia or
gies for evading complement include incorporation of meningoencephalitis depending on the route of inocula-
host RCA proteins into virions, encoding secreted or tion (Terry et al., 2000; Rajcani et al., 1985). Host resis-
tance to acute infection involves T cells, IFN, chemo-
kines, and STAT1 (Kulkarni et al., 1997; Ehtisham et al.,4 Correspondence: virgin@pathbox.wustl.edu (H.W.V.), sspeck@
rmy.emory.edu (S.H.S) 1993; Dutia et al., 1999). During chronic infection, HV68
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can establish latency or, in immunocompromised (e.g., tional stop codon in the HV68 RCA gene at bp 10,023
could result in the generation of an 50 amino acidIFN/ or IFN receptor/) mice, undergo persistent
replication. Persistent replication is associated with se- truncated protein with an intact signal sequence (Figure
1C). However, we did not detect truncated forms of thevere disease including splenic fibrosis and vasculitis
restricted to the great elastic arteries (Clambey et al., RCA protein on Western blots (Figure 1D and data not
shown), and supernatants from cells infected with2000; Usherwood et al., 2000; Weck et al., 1997; Dal
Canto and Virgin, 1999, 2000; Dutia et al., 1997; Dal HV68-RCAstop did not block C3 deposition on acti-
vated zymosan particles (Kapadia et al., 1999) (data notCanto et al., 2000; Tibbetts et al., 2002). Persistent repli-
cation is regulated by T cells, B cells, and IFN (Ush- shown). Therefore, the RCAstop mutation eliminated ex-
pression of functional RCA protein. Insertion of theerwood et al., 1996, 2000; Weck et al., 1999a; Tibbetts
et al., 2002; Christensen et al., 1999; Kim et al., 2002) RCAstop mutation did not change transcript levels from
adjacent genes M4 or gene 6 in infected fibroblastsand is a viral process that is distinct from acute replica-
tion since it requires different viral genes (Gangappa et (Figure 1E), indicating that phenotypes of the RCAstop
mutation were not attributable to unanticipated effectsal., 2002). HV68 establishes latency in B cells, macro-
phages, and dendritic cells (Weck et al., 1996, 1999b; of the RCAstop mutation on transcription of adjacent
genes.Flano et al., 2000; Sunil-Chandra et al., 1992). HV68
latency is regulated by T cells, B cells, IFN, and perforin
(Weck et al., 1999a; Topham et al., 2001; Gangappa The HV68 RCA Protein Is Not Essential for Viral
et al., 2002; Flano et al., 1999; Kulkarni et al., 1997; Replication during Acute Infection
Usherwood et al., 2000). Consistent with previous findings (Adler et al., 2000),
Two sets of considerations suggested that comple- HV68-RCAstop replicated normally in cultured NIH
ment and the HV68 RCA protein might be important in 3T12 fibroblasts (Figure 1F), demonstrating that the
specific in vivo settings. First, CNS cells can express gene is not essential for viral replication in vitro. To
most complement components, particularly after cyto- determine whether the HV68 RCA protein is involved
kine stimulation or viral infection (Johnston et al., 2001; in replication during acute infection in vivo, adult B6
Morgan and Gasque, 1996; Speth et al., 2002), and mice were infected with HV68-RCAstop and wild-type
mRNAs for multiple complement components are HV68. In normal B6 mice HV68-RCAstop titers were
upregulated in the CNS of virus-infected mice (Johnston modestly decreased on day 4 (2.5-fold, p  0.0084) and
et al., 2001; Terry et al., 2000). We therefore reasoned day 9 (2.9-fold, p  0.0833) postinfection in the spleen
that complement might play a role in controlling menin- (Figure 2A) but not liver or lung after i.p. inoculation
goencephalitis observed after intracranial (i.c.) inocula- (data not shown). In contrast, no defect in acute splenic
tion of HV68 (Terry et al., 2000; van Berkel et al., 2002). replication of HV68-RCAstop was observed in C3/
Second, complement regulates multiple aspects of B mice (Figure 2B). We further assessed HV68-RCAstop
cell biology (Ochsenbein et al., 1999; Carroll and Fischer, growth in 21-day-old CD-1 mice after i.p. inoculation.
1997; Prodeus et al., 1997, 1998). Since HV68 estab- HV68-RCAstop titers were decreased 2.3- to 3.8-fold
lishes latent infection in B cells (Weck et al., 1996, 1999a, in the lung (p  0.0005, Figure 2C) and spleen (p 
1999b; Flano et al., 2000; Sunil-Chandra et al., 1992) and 0.0119, Figure 2C). These data indicate that complement
B cells regulate HV68 latency (Weck et al., 1999a), we and the HV68 RCA protein may play a modest role in
considered it possible that complement might be impor- controlling acute viral replication in spleen, liver, and
tant during latent HV68 infection. lung of immunocompetent mice after i.p. inoculation.
To determine the role of complement and the HV68 However, the physiologic significance of such small
RCA protein in vivo, we utilized HV68 RCA protein mu- changes in viral titer is not clear.
tant viruses and mice lacking C3 or complement factor
B. We found that complement plays a crucial role during The HV68 RCA Protein Is a Virulence Factor
acute, persistent, and latent HV68 infection. The HV68 during Acute and Chronic Infection
RCA protein effectively counteracts some but not all of We next examined the role of the HV68 RCA protein
these actions of complement in vivo. in two established models of HV68 virulence: acute
lethal meningoencephalitis in weanling wild-type mice
and mortality during persistent infection of IFNR/Results
mice. HV68-RCAstop was less virulent than either
HV68 or HV68-RCAstop.MR after i.c. inoculation (Fig-Disruption of the HV68 RCA Protein Open
Reading Frame ure 2D). The LD50 was 1 pfu for wild-type HV68 and
HV68-RCAstop.MR, while the LD50 for HV68-RCAstopHV68-RCAstop and a control marker rescue virus
(HV68-RCAstop.MR) were constructed by homologous was approximately 100-fold higher (p  0.0001 for the
10 and 100 pfu dose, Figure 2D). HV68-RCAstop wasrecombination (Figure 1A). Their genomic structure
(probe A in Figure 1B) and the absence of deletions at also significantly attenuated during persistent infection
of IFNR/ mice (p  0.0249, Figure 2E). The decreasethe left end of the genome (Clambey et al., 2000; Van
Dyk et al., 2000) (probe B in Figure 1B) were confirmed in virulence in acutely infected weanling mice and
IFNR/ mice was due to the stop mutation in theby Southern blot analysis. HV68-RCAstop infected
cells did not express the three known isoforms of the HV68 RCA gene since virulence was fully restored in
HV68-RCAstop.MR (Figures 2D and 2E). These dataHV68 RCA protein (Kapadia et al., 1999) (Figure 1D).
Expression of HV68 RCA protein was restored in demonstrate that the HV68 RCA protein is a virulence
factor during acute and chronic infection.HV68-RCAstop.MR (Figure 1D). Insertion of a transla-
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Figure 1. Construction and Characterization of the HV68-RCAstop Mutant Virus
(A) Genomic structure of wild-type (WT) HV68, HV68-RCAstop, and marker rescue (MR) viruses. Probe A is the MluI-MfeI fragment from bp
7949 to 10,584 of the HV68 genome (Virgin et al., 1997). Probe B is the HindIII-EcoRV fragment from bp 11,100 to 14,026 of the HV68
genome (Clambey et al., 2000; Van Dyk et al., 2000; Virgin et al., 1997). pA, polyadenylation signals. Adjacent ORFs (M4 and G6) are shown
(Virgin et al., 1997).
(B) Southern blot analysis using probe A with HpaISpeI digestion (left panel) and probe B with Notl and Nsil digestion (right panel) of HV68
DNA. Note the 4.041, 1.357, and 0.758 kb fragments with HV68-RCAstop DNA, as compared to the 4.041 and 2.114 kb fragments with wild-
type and marker rescue viruses. Probe B did not detect smaller fragments in either wild-type HV68, HV68-RCAstop, or HV68-RCAstop.MR
viruses, indicating that no large deletions occurred at the left end of the genome (right panel).
(C) Sizes of putative truncated HV68 RCA protein products generated by the mutant viruses.
(D) Western blot analysis to detect expression of the different HV68 RCA protein isoforms (MW 60–65, 50–55, and 40–45 kDa).
(E) Real-time RT-PCR analysis of M4 and gene 6 transcription in NIH 3T12 cells infected with either wild-type HV68, HV68-RCAstop, or
HV68-RCAstop.MR. Gene 6 and gene 72 (v-cyclin) transcription was analyzed in parallel as controls. Shown are mean  SEM of pooled data
from four independent experiments.
(F) Multistep growth of wild-type HV68 and HV68-RCAstop.
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Figure 2. Growth and Virulence of HV68-RCAstop
(A and B) Acute splenic viral titers at days 4 and 9 after i.p. inoculation in adult B6 and C3/ mice.
(C) Acute viral splenic and lung titers in 21-day-old wild-type CD-1 mice after i.p. inoculation. Mice were sacrificed, and organs were harvested
5 days postinfection. For (A)–(C), shown are mean  SEM of pooled data from two independent experiments (at least ten mice total per
condition).
(D) Survival of weanling CD-1 mice after i.c. inoculation of HV68-RCAstop. Mice were infected with the indicated virus, and survival was
assessed after 14 days of infection. Each point represents between 20–30 mice per dose for each virus from at least three independent
experiments.
(E) Survival of adult IFNR/ mice infected with HV68-RCAstop, HV68-RCAstop.MR, and wild-type HV68. n, number of mice.
(F–H) Viral titers after i.c. inoculation of 21-day-old CD-1 mice with 100 pfu of virus. Shown are mean  SEM of pooled data from at least two
independent experiments (ten mice per virus per time point).
Critical Role for the HV68 RCA Protein in Immunofluorescence staining revealed viral antigen-
positive cells in the meninges and the brain parenchymaMeningoencephalitis during Acute Infection
The most significant (100-fold) attenuation attributable of wild-type HV68-infected mice 5 days postinfection
(Figures 3A–3C). Consistent with the observed lowerto loss of the HV68 RCA protein was observed after i.c.
inoculation of weanling mice (Figure 2D). In this setting, viral titers (Figure 2F), staining was significantly de-
creased in HV68-RCAstop-infected mice compared toattenuation of HV68-RCAstop was associated with an
27-fold decrease in viral growth in the CNS compared wild-type HV68-infected mice (compare Figures 3A to
3G and Figures 3B to 3H). We detected the HV68 RCAto HV68 or HV68-RCAstop.MR (p  0.0001, Figure
2F). HV68-RCAstop also failed to efficiently spread to protein in the meninges of infected mice (Figures 3D
and 3E). While staining with the polyclonal anti-HV68and replicate in the lung (p  0.0377, Figure 2G) and
spleen (p  0.0035, Figure 2H) after i.c. inoculation. To antibody revealed viral proteins in both the cytoplasm
and in the nucleus of virus-infected parenchymal cellsassure that the critical role for the HV68 RCA protein
in meningoencephalitis was not specific to CD-1 mice, (Figures 3C and 3I), the HV68 RCA protein was re-
stricted to the cytoplasm and plasmalemma of infectedwe confirmed that HV68-RCAstop is attenuated after
i.c. inoculation of 129 x B6 F1 mice (see below) and that CNS cells (Figures 3E, inset, and 3F). The potential physi-
ologic role of cytoplasmic HV68 RCA protein is notgrowth of HV68-RCAstop was significantly decreased
in brains, spleen, and lungs of inbred 129 x B6 F1 mice known.
In mice infected with wild-type HV68, the number ofafter i.c. inoculation (data not shown). It is interesting
to note that the effect of complement on HV68 patho- infected brain parenchymal cells increased between 5
and 7 days postinfection (Figure 4). The HV68 RCAgenesis was greatest in the CNS where it is generally
considered that complement levels are low in the ab- protein played a key role in promoting parenchymal inva-
sion since HV68-RCAstop infected 10-fold fewer pa-sence of inflammation.
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Figure 3. HV68 Antigen in the Brains of Mice with Meningoencephalitis
Shown are saggital sections of the cerebellum from CD-1 mice infected for 5 days with wild-type HV68 (A–F) or HV68-RCAstop (G–I).
Sections were immunostained using either anti-HV68 polyclonal antibody (A–C and G–I) or anti-HV68 RCA polyclonal antibody (D–F). (B),
(E), and (H) are magnifications of the boxed regions in (A), (D), and (G). Arrows denote viral antigen-positive cells. In (E), the asterisk denotes
the cell shown in the inset. No antigen was detected with the preimmune serum or in mock-infected mice (data not shown). These images
are representative of eight to ten mice per group. FACS analysis demonstrated that the polyclonal anti-HV68 antibody bound with similar
efficiency to NIH 3T12 cells infected with either HV68-RCAstop or wild-type HV68 (data not shown). Thus, the decreases in meningeal viral
antigen and the number of infected parenchymal cells in mice infected with HV68-RCAstop was not an artifact of the HV68 RCA protein
being the dominant antigen recognized by the polyclonal anti-HV68 antibody.
renchymal cells than wild-type HV68 7 days after infec- mutant in the virulence gene (HV68-RCAstop), and this
tion (p  0.002, Figure 4E). restoration of virulence should be specific to both the
viral gene and the host gene involved.
If the HV68 RCA protein effectively inhibits C3-medi-C3-Mediated Resistance Is the Physiologic Target
ated host defense, then the presence or absence of C3of the HV68 RCA Protein In Vivo
in the host should make no difference for viral virulenceSince SCR-containing proteins can have activities other
as long as the HV68-RCA protein is present. Consistentthan complement regulation, we evaluated whether the
with this, there was no difference in kinetics of lethalityrole of the HV68 RCA proteins in virulence was due
or the percentage of mice that die between CD-1 mice,to regulation of complement. We therefore applied a
wild-type 129 x B6 F1 mice, C3/ mice, or factor B/genetic test (host complementation), previously used to
mice infected with wild-type HV68 (Figures 5A–5D).prove that the HSV ICP34.5 protein targets PKR-depen-
129 x B6 F1 mice were included as a control for C3/dent processes in vivo (Leib et al., 2000) and that the HSV
and factor B/ mice, which are on a mixed 129 x B6gC protein acts in vivo to target complement (Lubinski et
background (Matsumoto et al., 1997).al., 1998, 1999; Friedman et al., 1996). In this test, re-
HV68-RCAstop was significantly attenuated in viru-moval of the host target (C3) of a viral virulence gene
(HV68 RCA protein) should restore virulence to a viral lence in weanling CD-1 mice (p  0.0095, Figure 5A).
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Figure 4. The Frequency of Virus-Positive Parenchymal Cells 7 Days Postinfection
Virus antigen-positive cells in the parenchyma of CD-1 mice infected with wild-type HV68 (A and B) or HV68-RCAstop (C and D). (B) and
(D) are magnifications of the boxed regions in (A) and (C). Arrows denote viral antigen-positive cells. In (E), the number of parenchymal cells
staining positive for viral antigen was quantitated by three individuals counting antigen-positive cells in a blinded manner (see Experimental
Procedures). The numbers on top of the bars represent the number of mice per group.
As expected from studies in CD-1 mice (Figures 2D and HV68-RCAstop virulence by deletion of C3, we per-
formed two additional experiments. First, we infected5A), HV68-RCAstop was significantly attenuated in 21-
day-old 129 x B6 F1 mice (p  0.0001, Figure 5B). Con- C3/ and wild-type mice with HV68-Cyclin.LacZ (Van
Dyk et al., 2000). HV68-Cyclin.LacZ was attenuatedsistent with the HV68 RCA protein targeting C3-depen-
dent host resistence, deletion of C3 in the host restored after i.c. inoculation of both 129 x B6 F1 mice (p 
0.0001, Figure 5B) and C3/ mice (p  0.0025, Figurevirulence of HV68-RCAstop to wild-type levels (p 
0.0102, Figure 5C). 5C). Furthermore, deletion of factor B from the host did
not restore virulence of HV68-RCAstop (Figure 5D).To determine the specificity of the restoration of
Complement Evasion in -Herpesvirus Infection
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compared to 1 pfu/15,600 splenocyte equivalents for
wild-type HV68, p 0.0002). In the course of evaluating
latency in C3/ mice, we also detected a modest in-
crease in persistent replication of wild-type HV68 in
PEC but not splenocytes of C3/mice (p0.038, Figure
6C). Persistent replication of HV68-RCAstop in C3/
PEC was similar to that seen with wild-type HV68 (Fig-
ure 6C), demonstrating that the presence of the HV68
RCA protein does not alter persistent replication in C3/
mice. These data suggest that complement plays a role
in controlling persistent HV68 infection and that this
effect is countered by the HV68 RCA protein.
Complement, but Not the HV68 RCA Protein,
Regulates Viral Latency
We next evaluated the role of complement in viral la-
tency. Latency is the presence of reactivatible viral ge-
nome within cells in the absence of infectious virus and
represents the primary mechanism by which herpesvi-
ruses maintain life-long infection. We infected C3/
mice and control wild-type 129, B6, and 129 x B6 F1
mice with wild-type HV68 and evaluated the establish-
ment of an ex vivo reactivation from latency 16 days
later. The frequency of reactivating cells was compara-
ble in 129, B6, and 129 x B6 F1 mice (1 in 1514–2016
for PEC, and 1 in 100,000 for splenocytes, Figure 7A).Figure 5. In Vivo Host Complementation of HV68-RCAstop Attenu-
However, the frequency of PEC reactivating from latencyation
was increased in C3/ mice (Figure 7A, 1 in 431 forTwenty-one-day-old wild-type CD-1 mice (A), 129 x B6 F1 mice (B),
C3/ mice (C), and factor B/ mice (D) were infected with 100 pfu PEC) compared to wild-type mice (129 [p  0.0002], B6
of virus, and survival was plotted versus time postinfection. This [p  0.0012], and 129 x B6 F1 [p  0.0005]). The fre-
data is pooled from at least three independent experiments with a quency of C3/ splenocytes reactivating from latency
total of 30 CD-1 mice, 14 C3/ mice, 15 factor B/ mice, and 20 (Figure 7A, 1/48,420 splenocytes) was also increased
129 x B6 F1 mice infected with wild-type HV68; 30 CD-1, 20 C3/
compared to control wild-type mice (129 [p  0.0134],mice, 42 factor B/ mice, and 20 129 x B6 F1 mice infected with
B6 [p  0.0194], and 129 x B6 F1 [p  0.0169]). TheHV68-RCAstop; and 26 C3/ mice and 20 129 x B6 F1 mice in-
fected with Cyclin.LacZ. increase in the PEC may be partly explained by an in-
crease in the frequency of C3/ PEC carrying viral ge-
nome (Figure 7B, 129 [p  0.016], B6 [p  0.0109], and
Thus, restoration of HV68-RCAstop virulence in C3/ 129 x B6 F1 [p  0.0254]), but no statistically significant
mice is specific for both the viral gene (HV68 RCA) difference was observed in viral genome bearing spleno-
and the host gene (C3 versus Factor B) involved. We cytes between C3/ and control mice (Figure 7B). The
therefore conclude that the HV68 RCA protein specifi- differences between the frequency of cells carrying viral
cally targets C3-dependent host resistance in vivo. genome in vivo and the frequency of cells undergoing
reactivation ex vivo is not fully understood, although
recent work shows that the immune system does controlThe HV68 RCA Protein Plays a Role in Persistent
the efficiency of HV68 ex vivo reactivation (Tibbetts etViral Replication in Immunocompromised
al., 2002).IFNR/ Mice
We next evaluated the role of the HV68 RCA proteinIn addition to virulence during acute infection, the HV68
in viral latency. The frequencies of PEC and splenocytesRCA protein played a role in virulence during persistent
reactivating HV68-RCAstop was comparable to thatreplication of IFNR/ mice (Figure 2E). Consistent with
seen with wild-typeHV68 in B6 mice (Figure 7C). Similarprior reports (Tibbetts et al., 2002; Gangappa et al., 2002;
to the results observed with wild-type HV68, the fre-Presti et al., 1998; Weck et al., 1997; Dal Canto et al.,
quency of cells reactivating HV68-RCAstop was in-2000), persistent replication was not detected in normal
creased in C3/ mice (Figure 7D). These data demon-mice at 16 days after infection (Figure 6A). Mortality in
strate that the presence of the HV68 RCA protein didIFNR/ mice (Figure 2E) is associated with high levels
not alter viral latency or the effect of complement onof persistent replication in both splenocytes and PEC
viral latency. Thus, the effect of C3 on latency (Figurethat is not observed in normal mice (p  0.0001, Figure
7A) is not evaded by the HV68 RCA protein.6B). Consistent with the requirement for the HV68 RCA
protein in virulence in these persistently infected mice,
we found that HV68 RCA protein was also required for Discussion
efficient persistent replication in IFNR/ splenocytes,
with HV68-RCAstop showing 6.5-fold less persistent These studies show that complement is an important
host defense against both acute and chronic -herpesvi-replication than wild-type HV68 (Figure 6B; 1 pfu/
100,000 splenocyte equivalents for HV68-RCAstop rus infection. Moreover, -herpesvirus RCA proteins can
Immunity
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Figure 6. Role of Complement and the HV68
RCA Protein in Persistent Replication
PEC and splenocytes from wild-type B6 (A),
C3/ (B), and IFNR/ (C) mice infected with
either wild-type HV68, HV68-RCAstop, or
HV68-RCAstop.MR were assessed for the
presence of persistently replicating virus at
day 16 postinfection. These data ( SEM) are
pooled from at least two independent experi-
ments.
play a key role in viral virulence via inhibition of C3- et al., 1998). In contrast to the in vitro setting, the HV68
RCA protein was important for viral replication in vivodependent host resistance in vivo. These findings are
in the CNS, although the effects of the HV68 RCA pro-particularly noteworthy in two major respects. First,
tein on replication in tissues outside of the CNS waswhile complement has been shown to have a key role
modest. The role of the HV68 RCA during replicationin acute viral infection, we made the unexpected obser-
in vivo is largely due to its function as an immune evasionvation that complement is important in controlling two
protein since deletion of C3 from the host normalizedcomponents of chronic herpesvirus infection: latency
growth and virulence of HV68 RCA protein mutantand persistent replication. Second, while the HV68 RCA
virus.protein was remarkably effective at countering the ef-
The 100-fold decrease in virulence of HV68 RCA mu-fects of complement during acute infection and persis-
tant virus after i.c. inoculation was associated with de-tent replication in immunocompromised IFNR/ mice,
creased viral growth, decreased viral antigen staining,it was ineffective at countering complement effects on
and decreases in the number of infected CNS parenchy-viral latency.
mal cells at later times of acute infection. Thus, the
HV68 RCA protein is an important virulence factor in
Role of the HV68 RCA Protein during Acute Infection this model of acute infection. The HV68 RCA protein
HV68-RCAstop virus replicates normally in cultured fi- is therefore biologically similar to the vaccinia virus RCA
broblasts in vitro, demonstrating that the protein is not protein VCP and the herpes simplex complement regula-
essential. This shows that the HV68 RCA protein is tor gC which also serve as virulence factors (Adler et
functionally distinct from poxvirus RCA proteins such al., 2001; Lubinski et al., 1998, 1999; Isaacs et al., 1992a;
as vaccinia B5R protein, which are involved in matura- Friedman et al., 1996; Smith et al., 1997). While the role
tion and cell to cell spread of poxviruses (del Mar et al., of the protein was most dramatic in CNS infection, there
1998; Isaacs et al., 1992b; Martinez-Pomares et al., 1993; were also modest effects of the RCA protein mutation
Engelstad and Smith, 1993; Wolffe et al., 1993; Taka- on acute replication (Figures 2A and 2C) and persistent
replication (Figures 2E and 6B) in the PEC. Therefore,hashi-Nishimaki et al., 1991; Herrera et al., 1998; Mathew
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Figure 7. Role of Complement and the HV68
RCA Protein in HV68 Reactivation from La-
tency
(A) Reactivation from latency in PEC and
splenocytes from C3/ mice and wild-type
control mice infected with wild-type HV68.
(B) Frequency of PEC and splenocytes posi-
tive for wild-type HV68 DNA in C3/ mice
compared to wild-type control mice.
(C) Reactivation from latency in PEC and
splenocytes from B6 mice infected with either
wild-type HV68 or HV68-RCAstop.
(D) Reactivation from latency in PEC and
splenocytes from C3/ mice infected with
either wild-type HV68 or HV68-RCAstop.
These data ( SEM) are pooled from at least
two independent experiments.
the effects of complement on HV68 lytic replication are may have roles independent of complement regulation
(del Mar et al., 1998; Isaacs et al., 1992b; Martinez-not specific for the CNS.
Pomares et al., 1993; Engelstad and Smith, 1993; Wolffe
et al., 1993; Takahashi-Nishimaki et al., 1991; HerreraThe Mechanism of Action of the HV68 RCA Protein
In Vivo et al., 1998; Mathew et al., 1998; Laquerre et al., 1998;
Sears et al., 1991; Lubinski et al., 1998). For example,The HV68 RCA protein functions in vivo by regulating
complement, since the attenuated phenotype of HV68- the vaccinia virus VCP protein also binds heparan sulfate
and is involved in interactions with human endothelialRCAstop is reversed by deletion of host C3, and this
reversal is specific for both C3 and the HV68 RCA cells (Smith et al., 2000). The HV68 RCA protein is very
effective in this immune evasion role since host C3 doesprotein. This is an important finding since RCA proteins
Table 1. Sequences of Primers Used in This Study
Size (bp)
Amplified DNA/Primer of Product Sense Primer (5	-3	) Antisense Primer (5	-3	)
RCAstop:lit28 fragment 1 2098 GCCACCTACGCGTCACGCATGa TAGCTCGTTAACTTCAGCGGAGCTGCAGGGTGa
RCAstop:lit28 fragment 2 303 TAGCTGAAGTTAACGGGTTCACACCAGGCGCa TTATGTCACATATGGGAGATTCCCCACTCCa
HV68-RCAstop outer primers 643 (primer A) AAGTTCAATTCCTTGTGCC (primer B) GGTTGGCCCATATAGCTTCAGATT
HV68-RCAstop inner primers 328 (primer C) GCAGCTCCGCTGAGGTTAb (primer D) TCGGGAGGTGCACACTTTT
HV68-RCAstop.MR primer NA GCAGCTCCGCTGTAGGCCb NA
HV68 gene 72 133 AAAGTCTGGATACCCTCTCG GAAGATTTTTGGGTGACAGAG
a The italicized DNA sequence represents introduced restriction enzyme sites. The underlined sequence represents sequence not found in
the template DNA being amplified.
b The bold sequence represents unique sequence in HV68-RCAstop DNA (primer C) and HV68-RCAstop.MR.
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not regulate the virulence of wild-type HV68 which ex- ure 2E). The importance of complement in the control
of persistent replication is confirmed by the finding ofpresses the RCA protein but does regulate the virulence
of HV68RCA.stop which lacks the RCA protein. persistent replication of wild-type HV68 in C3/ mice.
The mechanism(s) responsible for the roles of comple-The mechanism by which complement plays a role in
protecting the CNS from viral infection is not known. ment and the HV68 RCA protein in persistent replica-
tion are not clear. Either increased reactivation fromThe presence of the viral RCA protein in the meninges
and on the surface of infected cells in the brain raises latency in the absence of complement (see below) or
increased replication of wild-type HV68 compared tothe possibility that the viral RCA protein is protecting
infected cells from complement-mediated lysis. How- HV68-RCAstop, as was observed during acute replica-
tion, could contribute to enhanced persistent replicationever, both HV68 and HVS express soluble forms of the
RCA protein (Kapadia et al., 1999; Albrecht and Fleck- in immunocompromised mice. It is also possible that
complement activation during virus infection is neces-enstein, 1992), suggesting that inhibition of complement
activation in the fluid phase could also be important for sary for induction of immune responses that eliminate
persistent replication.host resistance. The relative contribution of complement
regulation in the fluid phase versus at the cell or virion
surface will have to be examined using viruses that are Role of Complement in -Herpesvirus Latency
unable to express either the soluble or membrane- We found an increased number of latently infected cells
bound isoforms of the HV68 RCA protein. in C3/ mice using an ex vivo reactivation assay, dem-
Since the soluble HV68 RCA protein isoform can onstrating that complement plays a role in -herpesvirus
regulate C3 deposition via both classical and alternative latency. The lack of effect of the HV68 RCA protein,
pathways (Kapadia et al., 1999), it was possible that despite its importance during acute infection and persis-
both the classical and alternative pathways could play tent replication in immunocompromised mice, was par-
a role in HV68 infection of the CNS. However, data ticularly striking. One explanation for this is that the
showing that deletion of factor B, which is critical for the HV68 RCA protein is a lytic cycle late protein and may
alternative pathway, does not reverse the attenuation of therefore not be expressed by latently infected cells
a HV68 RCA protein mutant suggests that the alterna- (Virgin et al., 1999; Kapadia et al., 1999). However, an-
tive pathway is not the primary target of the HV68 RCA other lytic cycle protein, the viral cyclin, has prominent
protein during acute infection of the CNS. This suggests effects on viral latency (Gangappa et al., 2002; Hoge et
that the classical and/or the mannose-binding lectin al., 2000; Van Dyk et al., 2000). If persistent replication
complement pathways are important for host resistance contributes to latency, it is possible that complement-
to HV68 (Kapadia et al., 1999). dependant regulation of reactivation from latency may
The general importance of complement regulation be due to effects on viral replication. It is also possible
during DNA virus infection is underlined by comparison that the effects of complement on viral latency are indi-
of the results presented here with studies of the HSV rect. Since B cells are critical for regulating HV68 la-
gC-1 protein. While this protein has complement-inde- tency (Weck et al., 1999a), a possible interaction be-
pendent functions, including in binding heparan sulfate tween B cells and complement in the regulation of
(Laquerre et al., 1998) and regulating infection of polar- latency is an attractive possibility. Consistent with this
ized epithelial cells (Sears et al., 1991; Lubinski et al., hypothesis, passive transfer of HV68-specific antibody
1998), it plays an important role in vivo by virtue of to latently infected B cell/ mice can efficiently inhibit
regulating complement (Lubinski et al., 1998, 1999; wild-type HV68 reactivation from latency (Gangappa
Friedman et al., 1996). The gC protein is not structurally et al., submitted; Kim et al., 2002). It is tempting to
homologous to the HV68 RCA protein. Thus, both - speculate that the effects of complement on latency
and -herpesviruses have evolved mechanisms for in- are secondary to the need for complement for B cell
hibiting C3 dependent immunity, but have done so via switching or antigen presentation to T cells (Carroll,
convergent evolution. 2000; Luxembourg and Cooper, 1994; Cherukuri et al.,
2001; Nielsen et al., 2000). Based on the data we present
Role of the HV68 RCA Protein and Complement here, it would also be interesting to assess the relation-
during Persistent Replication ship between complement-deficient patients and EBV
One of the more surprising findings of this study was or KSHV infection.
the role of complement and complement evasion during
Experimental Procedureschronic (latent and persistent) HV68 infection. One im-
portant component of chronic -herpesvirus infection
Virus, Viral Assays, and Tissue Cultureis persistent replication. At day 16, acute virus in the
HV68 clone WUMS (ATCC VR1465) was passaged and grown in
PEC and splenocytes is cleared by wild-type mice (Weck NIH 3T12 cells (Weck et al., 1996, 1997; Kapadia et al., 1999). Murine
et al., 1996, 1999a, 1999b; Clambey et al., 2000; Van Dyk embryo fibroblasts (MEF) were obtained from C57Bl/6 (B6) mice
(Weck et al., 1996). To assess viral growth in cultured cells, NIHet al., 2000). However, in immunocompromised mice,
3T12 cells were infected with mutant or wild-type HV68 viruses,including those lacking IFNor the IFNR, HV68 persis-
and viral titer was measured (Clambey et al., 2000; Van Dyk et al.,tently replicates at high levels (Tibbetts et al., 2002; Dal
2000). The level of detection for all plaque assays was 50 pfu (1.7Canto et al., 2000; Gangappa et al., 2002). We found
in log10).that the HV68 RCA protein was important for efficient
persistent replication in IFNR/ mice. The physiologic Generation of Recombinant HV68 Viruses
importance of this is shown by the decreased virulence The HV68-RCAstop targeting vector (RCAstop:lit28) was generated
using PCR mutagenesis from a genomic subclone plasmid (RCA:lit28)of a HV68 RCA protein mutant virus in these mice (Fig-
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containing the 7948 bp BglII-XhoI fragment (bp 5362–13,311) of et al., 2000; van Berkel et al., 2002). The number of viral antigen-
positive cells in the cortex was quantitated in two sections perHV68 cloned into Litmus 28 (New England Biolabs, Beverly, MA).
HV68 sequence from the MluI restriction site (bp 7949 of the HV68 mouse by three investigators counting in a blinded manner. For 5
days postinfection, six mice infected with wild-type HV68 and sixgenome) to bp 10,031 was amplified (fragment 1, primers in Table
1), while inserting two translational stop codons and a frameshift in mice infected with HV68-RCAstop were examined. For mice har-
vested 7 days postinfection, thirteen mice infected with wild-typethe HV68 RCA ORF. A unique HpaI restriction site was incorporated
for Southern blot analysis. HV68 sequence from bp 10,031 to NdeI HV68 and eight mice infected with HV68-RCAstop were examined.
restriction site (bp 10,309) was amplified (fragment 2, primers in
Table 1). Fragments 1 and 2 were digested with MluI/HpaI and HpaI/ Ex Vivo Analysis of HV68 Latency and Reactivation
NdeI, respectively, cloned into RCA:lit28 to generate RCAstop:lit28, The frequency of splenocytes or peritoneal cells that reactivate from
and sequenced (Sambrook et al., 1989; Clambey et al., 2000; Van latency ex vivo was determined using a limiting dilution reactivation
Dyk et al., 2000). assay (Weck et al., 1996, 1999a, 1999b; Van Dyk et al., 2000; Clambey
The HV68-RCAstop virus was generated by cotransfecting et al., 2000; van Berkel et al., 2002). Mechanical disrupted cells
RCAstop:lit28 with wild-type HV68 genomic DNA (Clambey et al., contained 1% live cells, and thus the presence of preformed virus
2000; Van Dyk et al., 2000; van Berkel et al., 2002; Gangappa et al., (persistent replication) was detected by serial dilution of mechani-
2002). Plaques were screened by nested PCR using outer primers cally disrupted cells (Weck et al., 1996, 1999a, 1999b; Van Dyk et
A and B (which amplify both wild-type HV68 and HV68-RCAstop al., 2000; Clambey et al., 2000). The frequency of peritoneal cells
DNA sequence, Table 1) and the inner primers C and D (specific or splenocytes harboring HV68 genome was determined using a
for HV68-RCAstop, Table 1). The marker rescue virus (HV68- limiting dilution nested PCR assay (Weck et al., 1996, 1999a, 1999b;
RCAstop.MR) was generated by cotransfecting RCA:lit28 plasmid Van Dyk et al., 2000; Clambey et al., 2000; van Berkel et al., 2002).
with HV68-RCAstop viral DNA (Clambey et al., 2000; Van Dyk et There were no false positive PCR reactions in the data in this report,
al., 2000; van Berkel et al., 2002). HV68-RCAstop.MR plaques were and all assays demonstrated approximately one copy sensitivity
selected by nested PCR using outer primers A and B and inner for plasmid DNA. For all experiments, data on latency, persistent
primer C together with a HV68-RCAstop.MR-specific primer (Table replication, and the frequency of genome-bearing cells was pooled
1). PCR conditions for HV68-RCAstop round 1 were: (1) denatur- from at least three experiments with five mice per group per exper-
ation at 95
C, 5	; (2) 35 cycles, 95
C, 1	; 54
C, 1	; 72
C, 2	; (3) exten- iment.
sion at 72
C, 5	; and (4) 4
C hold. PCR conditions for HV68-RCAstop
round 2 were: (1) denaturation at 95
C, 5	; (2) 35 cycles: 95
C, 1	; Statistical Analysis
51
C, 1	; 72
C, 1	; (3) extension at 72
C, 5	; and (4) 4
C hold. All data was analyzed using GraphPad Prism program (GraphPad
All viruses were plaque purified to homogeneity and confirmed Software, San Diego, CA) as previously described (Weck et al., 1996,
by nested PCR, Southern blot, and Western blot analyses (Clambey 1999a, 1999b; Van Dyk et al., 2000; Clambey et al., 2000; van Berkel
et al., 2000; Van Dyk et al., 2000; Kapadia et al., 1999; van Berkel et et al., 2002). Frequencies of reactivation and genome-positive cells
al., 2002). Twenty individual HV68-RCAstop and HV68-RCAstop. were obtained from cell numbers at which 63% of wells scored
MR plaques were assessed for correct integration of the mutation positive for either viral CPE or for presence of viral genome based
by probing HpaISpeI digested viral DNA with probe A (Figure 1A). on Poisson distribution. The data were then subjected to nonlinear
Analysis of the left end of the HV68 genome for deletions was regression analysis to obtain the single-cell frequency for each lim-
performed using probe B (Clambey et al., 2000; Van Dyk et al., 2000) iting dilution analysis.
(Figure 1A). Western blot analysis was performed to detect soluble
and membrane-associated HV68 RCA protein (Kapadia et al., Acknowledgments
1999). To detect truncated forms of the HV68 RCA protein, superna-
tants from virally infected cells were concentrated using Centriprep This work was supported by NIH RO1 AI45019 to H.W.V. B.L. was
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